Form 4: UNH CEO Hemsley Acquires 52 Shares via Dividends

UnitedHealth Group CEO Stephen J. Hemsley acquired 52 shares of common stock through dividend equivalents on vested deferred stock units.

Summary

• Stephen J. Hemsley, CEO and Director of UnitedHealth Group (UNH), acquired 52 shares of common stock on December 16, 2025.
• The acquired shares represent dividend equivalents paid on vested deferred stock units.
• These dividend equivalents were immediately vested and are subject to the same terms as the underlying deferred stock units.
• The transaction price for these shares was $0, as they were received as dividend equivalents.
• The transaction was made pursuant to a Rule 10b5-1(c) contract, instruction, or written plan.
• Following this transaction, Hemsley directly owns 427,947.942 shares of common stock.
• He also indirectly owns 351.9396 shares through a 401(k) plan and 681,875 shares through Trusts.

Sentiment

Score: 6

Explanation: The CEO acquired additional shares through dividend equivalents, which is a routine but generally positive sign of continued insider ownership and alignment with shareholder interests.

Positives

• The CEO acquired additional shares, even if through an automatic dividend reinvestment, which indicates continued alignment with shareholder interests.
• The transaction was executed under a Rule 10b5-1(c) plan, signifying a pre-arranged, non-discretionary transaction.

Future Outlook

This filing does not contain forward-looking statements or guidance.

Industry Context

This is a routine insider transaction report and does not provide information relevant to broader industry trends or competitors.

Comparison to Industry Standards

• This filing is a standard regulatory disclosure of an insider transaction and does not contain information for comparison to industry-specific benchmarks or projects.

Stakeholder Impact

• Shareholders: The transaction indicates continued alignment of the CEO's interests with shareholders through increased equity ownership.
• Employees, Customers, Suppliers, Creditors: No direct impact on these stakeholders is indicated by this filing.

Key Dates

Keywords

UnitedHealth Group, UNH, Stephen J. Hemsley, Form 4, insider transaction, beneficial ownership, common stock, dividend equivalents, 10b5-1 plan, CEO, director